Cancer treatment and survivorship statistics, 2019
Abstract The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and t...
Explore 176 academic publications
Abstract The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and t...
One camera and one low-cost inertial measurement unit (IMU) form a monocular visual-inertial system (VINS), which is the minimum sensor suite (in size, weight, and power) for th...
Potential conflict of interest: Dr. Hwang received grants from Merck and Gilead. Dr. Chang advises Arbutus. Dr. Lok received grants from Gilead and Bristol‐Myers Squibb. Dr. Jon...
This volume is based on a year's seminar in which Dr. Lacan addressed a larger, less specialized audience than ever before, among whom he could not assume familiarity with his w...
Abstract Since its first release over a decade ago, the MetaboAnalyst web-based platform has become widely used for comprehensive metabolomics data analysis and interpretation. ...
Abstract SwissTargetPrediction is a web tool, on-line since 2014, that aims to predict the most probable protein targets of small molecules. Predictions are based on the similar...
Abstract The number of cancer survivors continues to increase in the United States due to the growth and aging of the population as well as advances in early detection and treat...
BACKGROUND Nivolumab plus ipilimumab or nivolumab alone resulted in longer progression-free and overall survival than ipilimumab alone in a trial involving patients with advance...
Solar cells based on dye-sensitized mesoporous films of TiO2 arelow-cost alternatives to conventional solid-state devices1. Impressive solar-to-electrical energy conversion effi...
The mRNA-1273 vaccine induced anti-SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified. These findings support further develop...